Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

OXURION to Present at the Ophthalmology Day at BTIG

24 Nov 2021

Leuven, BELGIUM, Boston, MA, US - November 24, 2021 – 07.30 AM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in vascular retinal disorders, today announces its management will present and meet with investors at the Ophthalmology Day at BTIG: 

Ophthalmology Day at BTIG

Tuesday, November 30, 2021

Fireside Chat: 8:30 AM ET

For more information, please visit Oxurion's events page: